AccuLine

AccuLine is transforming cardiac care with accessible, AI-powered diagnostics for early detection of coronary artery disease.

Health Tech & Life Sciences
Active
Pre-Seed Petah Tikva, Israel Founded 2022
Last updated 2026-07-26
Total raised
$5.1M
Last: Seed 2024-07
Stage
Pre-Seed
Founded
2022
Headcount
30
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

AccuLine is a medical device startup founded with the vision to save millions of lives worldwide by preventing the next heart attack. AccuLine is developing CORA, an accurate, non-invasive, and cost-effective system for the early detection of coronary artery disease (CAD), aiming to replace inaccurate, time-consuming, and labor-intensive stress test exams. CORA uses advanced signal filtering and deep learning algorithms to analyze three biological signals: the heart's electrical function, oxygen saturation, and breathing phase, providing immediate, actionable results without radiation or contrast agents.

Funding history · 5 rounds · $5.1M total

2024-04
Grant $600K
2024-04
Grant $150K
2022-01
A Round Undisclosed
★ eHealth Ventures★ Maccabi Healthcare Services
Date unknown
Grant $930K
Date unknown
Seed $3.5M
★ eHealth Ventures★ Mayo Clinic Platform★ Maccabi Healthcare Services

Headcount over time

From 4 (2022-08) to 13 (2026-03) · +9 (+225%) · 13 points · source: Finder history + radar grounding
140 2022-08 2026-03

Q&A

What is AccuLine's primary focus?
AccuLine is a medical device startup focused on transforming cardiac care with accessible, AI-powered diagnostics for the early detection of coronary artery disease (CAD).
What is the name of AccuLine's core product?
AccuLine is developing CORA, a system designed for the early detection of coronary artery disease (CAD).
How does AccuLine's CORA system work?
CORA uses advanced signal filtering and deep learning algorithms to analyze three biological signals: the heart's electrical function, oxygen saturation, and breathing phase, providing immediate, actionable results without radiation or contrast agents.
When was AccuLine founded?
AccuLine was founded in February 2022.
What was AccuLine's most recent funding round?
In July 2024, AccuLine completed a Seed funding round, raising $4,200,000. Investors included eHealth Ventures and Maccabi Healthcare Services.
Which organizations provided grants to AccuLine in May 2024?
In May 2024, AccuLine received a grant of $600,000 from Google and the Israel Innovation Authority.
What strategic agreement did AccuLine announce in September 2023?
In September 2023, AccuLine announced a Know-How License Agreement with Mayo Clinic to advance the early detection of heart attacks.
Who are the co-founders of AccuLine?
The co-founders of AccuLine are Moshe Barel (CEO), Prof. Aharon Frimerman (CMO), and Prof. Shai Revzen (CSO).

Team · 4

Moshe Barel
Founder · CEO & Co-Founder
Prof. Aharon Frimerman
Founder · CMO & Co-Founder
Prof. Shai Revzen
Founder · CSO & Co-Founder
Benny Shani
Founder · CTO & Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningData StorageCloud
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicespreventionmachine-learningearly-detectionheart-failurealgorithmsartificial-intelligencenon-invasivedigital-healthcarediagnosticscardiovascularhealthcaresignal-processingcardiology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteacculine-medical.com
LinkedInlinkedin.com/company/82039359

Identifiers & details

Founded2022-2
Employees (exact)30

Radar intelligence

Patents

EPO9

Web history (Wayback)

Domainacculine-medical.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516557170
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-02-09
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens1
Registry events5 — shares_capital (2), charge (1), other (1), people (1)
Registered addressרפאל איתן 2 פתח תקווה

Recent registry events

DateEvent
2025-10-23הקצאת מניות
2025-10-23העברת מניות
2026-04-23רישום שעבוד
2025-11-13שינוי בתקנון
2025-11-12עדכון דירקטורים-הסרת דירקטור